Coloplast

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Coloplast A/S
Type Publicly traded Aktieselskab
Traded as OMXCOLO B
Industry Health care
Founded 1957
Headquarters Humlebæk, Denmark
Key people Lars Rasmussen (President and CEO), Michael Pram Rasmussen (Chairman)
Products Ostomy bags, continence products, urology products, wound dressings
Revenue DKK 10.17 billion (2010/2011)[1]
Operating income DKK 2.581 billion (2010/2011)[1]
Profit DKK 1.819 billion (2010/2011)[1]
Total assets DKK 9.218 billion (September 2011)[1]
Total equity DKK 4.478 billion (September 2011)[1]
Employees 7,330 (FTE, average 2010/2011)[1]
Website www.coloplast.com

Coloplast is an international company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care.

Coloplast was founded in 1957, employs more than 7,500 people and operates around the world, with sales activities in 53 countries and production in Denmark, Hungary, France, China and the US.[2] It has its headquarters in Humlebæk, Denmark. Its U.S. headquarters is in Minneapolis, Minnesota.

The company supplies products to hospitals and institutions as well as wholesalers and retailers. In selected markets, Coloplast is a direct supplier to consumers.

The company had revenues of DKK 10.17 billion in 2010/2011. Europe constitutes the biggest market with 73% of sales while 17% of sales are in North America and 10% in the rest of the world.

Coloplast is noted on the Danish Stock Exchange, and has for a number of years been represented among the 20 most traded shares in the country.

Coloplast was included in Ethisphere's 2012 edition of the "World's Most Ethical Companies" listing.[3] In 2013 Coloplast was listed as the 12th most innovative company by Forbes Magazine[4]

References[edit]

  1. ^ a b c d e f "Annual Report 2010/2011". Coloplast. Retrieved 15 November 2011. 
  2. ^ [1]
  3. ^ [2]
  4. ^ [3]

External links[edit]